Torrent Pharma’s ₹25,689-crore acquisition of JB Chemicals boosts its chronic portfolio and expands its global reach. But ...

The acquisition involves Torrent Pharma buying a 46.39 per cent stake from global investment firm KKR and an additional 2.8 ...

KKR sold off its 46.39% stake in J.B. Chemicals and Pharmaceuticals to Torrent Pharma after grooming the Indian drugmaker ...

The deal grants Torrent Pharma access to a thriving pharmaceutical business. JB Pharma makes drugs for gastroenterology, ...

Torrent said on Sunday that it would acquire a controlling stake in JB Pharma from global investment firm KKR, at an equity ...

Torrent has signed definitive agreements to acquire stake in JB Pharma at an equity valuation of Rs256.89bn ($3bn) on a fully ...

The deal is expected to strengthen Torrent's market share in the Indian pharmaceutical market and diversify its platform into ...

Torrent Pharmaceuticals to acquire 46.39% stake in JB Chemicals and Pharmaceuticals, merging to strengthen global presence.

Notwithstanding the medium-term gains, the acquisition of JB Chemicals & Pharmaceuticals brings uncertainty over successful ...

Torrent Pharma makes a bold ₹18,000 crore move to acquire JB Chemicals, signalling a strategic comeback and consolidation ...

According to Nuvama Institutional Equities, TRP will initially acquire a 46.39 per cent stake in JBCP from private equity ...

India's Torrent Pharmaceuticals said on Sunday it will acquire a 46.39% controlling stake in smaller peer JB Chemicals and Pharmaceuticals from New York-based investment firm KKR , and plans to merge ...